1 of 2nächste Seite
Financial Report
Bayer Group Key Data
 20052006Change
 € million € million%
Bayer Group   
Net sales24,70128,956+17.2
EBITDA14,1224,675+13.4
EBITDA before special items4,6025,584+21.3
EBIT22,5142,762+9.9
EBIT before special items3,0473,479+14.2
Income before income taxes1,9121,980+3.6
Net income1,5971,683+5.4
Earnings per share (€)32.192.22+1.4
Gross cash flow43,1143,913+25.7
Net cash flow53,2273,928+21.7
Capital expenditures1,2101,739+43.7
Research and development expenses1,7292,297+32.9
Dividend per Bayer AG share (€)0.951.00+5.3
    
Bayer HealthCare   
Net external sales7,99611,724+46.6
EBITDA11,2801,947+52.1
EBITDA before special items1,4872,613+75.7
EBIT29231,313+42.3
EBIT before special items1,1771,715+45.7
Gross cash flow49231,720+86.3
Net cash flow51,0871,526+40.4
Capital expenditures225576+156.0
    
Bayer CropScience   
Net external sales5,8965,700-3.3
EBITDA11,2841,166-9.2
EBITDA before special items1,2731,204-5.4
EBIT2690584-15.4
EBIT before special items685641-6.4
Gross cash flow4964900-6.6
Net cash flow5904898-0.7
Capital expenditures201197-2.0
    
Bayer MaterialScience   
Net external sales9,44610,161+7.6
EBITDA11,7211,499-12.9
EBITDA before special items1,7641,677-4.9
EBIT21,250992-20.6
EBIT before special items1,2931,210-6.4
Gross cash flow41,2541,166-7.0
Net cash flow51,3371,281-4.2
Capital expenditures642753+17.3
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
Search
Search
Download Center
Links
Services
Calendar
 
 
Info
zoom - normal view 100% zoom +